{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:07:14Z","timestamp":1787170034873,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000266","name":"EPSRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ejmech.2021.113431","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T21:04:56Z","timestamp":1618952696000},"page":"113431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5815-6962","authenticated-orcid":false,"given":"Aini","family":"Vuorinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6987-3235","authenticated-orcid":false,"given":"Isabel V.L.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chatzopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Squire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Fairclough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-825X","authenticated-orcid":false,"given":"Noelia Araujo","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh A.","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-8377","authenticated-orcid":false,"given":"Daniel","family":"Conole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2176-4902","authenticated-orcid":false,"given":"James R.","family":"Donald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3245-5280","authenticated-orcid":false,"given":"Nicky J.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3278-6074","authenticated-orcid":false,"given":"R. Fernando","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4840-3277","authenticated-orcid":false,"given":"Francis X.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham M.","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-9369","authenticated-orcid":false,"given":"Angela J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113431_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coph.2017.04.002","article-title":"Pharmacological advances for treatment in Duchenne muscular dystrophy","volume":"34","author":"Guiraud","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113431_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/21678707.2018.1438261","article-title":"The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy","volume":"6","author":"Guiraud","year":"2018","journal-title":"Expert Opin. Orphan Drugs."},{"key":"10.1016\/j.ejmech.2021.113431_bib3","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1021\/jm200135z","article-title":"Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of duchenne muscular dystrophy","volume":"54","author":"Chancellor","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113431_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019189","article-title":"Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse","volume":"6","author":"Tinsley","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.113431_bib5","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1021\/acs.jmedchem.9b01547","article-title":"Isolation, structural identification, synthesis, and pharmacological profiling of 1,2-trans-Dihydro-1,2-diol metabolites of the utrophin modulator ezutromid","volume":"63","author":"Chatzopoulou","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113431_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152840","article-title":"Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to pediatric patients with duchenne muscular dystrophy","volume":"11","author":"Ricotti","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.113431_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00204-014-1423-3","article-title":"Firefly luciferase inhibition: a widely neglected problem","volume":"89","author":"Braeuning","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113431_bib8","doi-asserted-by":"crossref","first-page":"103395","DOI":"10.1016\/j.bioorg.2019.103395","article-title":"Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferase","volume":"94","author":"Wilkinson","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113431_bib9","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/anie.201912392","article-title":"Chemical proteomics and phenotypic profiling identifies the aryl hydrocarbon receptor as a molecular target of the utrophin modulator ezutromid","volume":"59","author":"Wilkinson","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113431_bib10","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113431_bib12","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.1021\/acs.jmedchem.7b01921","article-title":"Emerging approaches for the identification of protein targets of small molecules - a practitioners\u2019 perspective","volume":"61","author":"Comess","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113431_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2020.09.016","article-title":"Combining experimental strategies for successful target deconvolution","author":"Wilkinson","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2021.113431_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1039\/C6NP00001K","article-title":"Chemical proteomics approaches for identifying the cellular targets of natural products","volume":"33","author":"Wright","year":"2016","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2021.113431_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4155\/fmc.14.152","article-title":"Photoaffinity labeling in target- and binding-site identification","volume":"7","author":"Smith","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113431_bib16","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1021\/acs.jmedchem.7b01561","article-title":"Fishing for drug targets: a focus on diazirine photoaffinity probe synthesis","volume":"61","author":"Hill","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113431_bib17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/acs.accounts.7b00606","article-title":"Constructing new bioorthogonal reagents and reactions","volume":"51","author":"Row","year":"2018","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113431_bib18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1021\/acs.bioconjchem.7b00633","article-title":"Practical considerations, challenges, and limitations of bioconjugation via azide-alkyne cycloaddition","volume":"29","author":"Pickens","year":"2018","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2021.113431_bib19","series-title":"Ring-annulated Dihydropyrrolo[2,1-Alpha]isoquinolines, US 2011 0028450 A1","author":"Timmers","year":"2011"},{"key":"10.1016\/j.ejmech.2021.113431_bib20","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1002\/anie.201310280","article-title":"Cyclization of gold acetylides: synthesis of vinyl sulfonates via gold vinylidene complexes","volume":"53","author":"Bucher","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113431_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmech.2014.05.032","article-title":"Synthesis and in\u00a0vitro antitumor activity of novel 2-alkyl-5- methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives","volume":"82","author":"Mori","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113431_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1006868130002","article-title":"Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse","volume":"183","author":"Kuznetsov","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2021.113431_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/hmg\/dds415","article-title":"Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of duchenne muscular dystrophy are not alleviated by PDE5 inhibition","volume":"22","author":"Percival","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2021.113431_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115763","article-title":"Defects in mitochondrial ATP synthesis in dystrophin-deficient Mdx skeletal muscles may be caused by complex I insufficiency","volume":"9","author":"Rybalka","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.113431_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jcsm.12527","article-title":"Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients","volume":"11","author":"Capitanio","year":"2020","journal-title":"J.\u00a0Cachexia. Sarcopenia Muscle."},{"key":"10.1016\/j.ejmech.2021.113431_bib26","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/hmg\/ddr265","article-title":"Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle","volume":"20","author":"Ljubicic","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2021.113431_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/hmg\/ddv444","article-title":"Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles","volume":"25","author":"P\u00e9ladeau","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2021.113431_bib28","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1093\/hmg\/ddp431","article-title":"Pharmacological activation of PPAR\u03b2\/\u03b4 stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice","volume":"18","author":"Miura","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2021.113431_bib29","unstructured":"STRING: Functional Protein Association Networks, (n.d.). https:\/\/string-db.org\/(accessed April 15, 2020)."},{"key":"10.1016\/j.ejmech.2021.113431_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw100","article-title":"The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins","author":"Rouillard","year":"2016","journal-title":"Database"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:29:01Z","timestamp":1759328941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421002804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":29,"alternative-id":["S0223523421002804"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113431","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113431"}}